The presentation begins at 2:00 PM PT and is expected to run for one hour. Investors and analysts can access the discussion via a live webcast on the company’s investor relations portal, where accompanying slide decks will be published ahead of the event. For those joining by phone, the domestic access number is 1-800-836-8184, while international participants should dial +1-646-357-8785, using Conference ID 21785.

Following the live broadcast, the company will maintain an archive of the presentation on its website for one year. Envista, which manages a suite of over 30 brands including Nobel Biocare, Ormco, and DEXIS, continues to utilize its internal business system to drive its global dental technology strategy. Jim Gustafson, Vice President of Investor Relations, serves as the primary contact for inquiries regarding the upcoming disclosure.